Skip to main content

American Conference Institute Disputes


Date: October 7, 2020

Mintz is proud to sponsor the ACI Paragraph IV Disputes conference.  Each year, leading pharmaceutical patent litigators for brand name and generic drug companies gather to discuss, debate, and analyze the latest trends, judicial rulings, and legislative developments affecting Hatch-Waxman litigation.  Mintz Members, Kathleen Carr and

Mintz Member, Kathleen Carr, will be speaking on a panel entitled, “New Studies in Obviousness: Thoughts on Inherency, Structure, Prior Art and Secondary.” 

Mintz Member, Dave Conlin, will be speaking on a session entitled, “Ethics and New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena.”

Register for Event


Professional Cropped Carr Kathleen Mintz

Kathleen B. Carr


Kathleen B. Carr is a Mintz attorney with more than 20 years of experience as lead counsel on federal and state court cases. She has led trial teams on Hatch-Waxman pharmaceutical patent litigation, and she's registered to practice before the US Patent and Trademark Office.
Professional Cropped Conlin Dave Mintz

David G. Conlin


David G. Conlin helps plan, establish, maintain, and enforce clients’ intellectual property portfolios for Mintz. He assists clients with protecting their freedom to operate amid improperly alleged IP infringement, and his teams have driven the issuance of over 3,700 patents.